Danske Bank’s Xenon Pharmaceuticals XENE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$3.72K Hold
100
– – ﹤0.01% 925
2026
Q2
$6.04K Hold
100
– – ﹤0.01% 899
2026
Q1
$5.82K Sell
100
-700
-88% -$32.3K ﹤0.01% 895
2025
Q4
$35.9K Hold
800
– – ﹤0.01% 1078
2025
Q3
$32.1K Hold
800
– – ﹤0.01% 1098
2025
Q2
$25K Buy
+800
New +$26.1K ﹤0.01% 1146
2024
Q4
– Sell
-100
Closed -$3.94K – 1671
2024
Q3
$3.94K Buy
+100
New +$4.03K ﹤0.01% 1448

Other funds holding XENE

Danske Bank's XENE Position: Q3 2026 in Review

Danske Bank held its Xenon Pharmaceuticals (XENE) position steady in Q3 2026 at 100 shares worth $3.72K. The position accounts for ﹤0.01% of the portfolio, ranked #925.

Danske Bank first reported a position in XENE in Q3 2024 and has held it in 7 quarters since. The position peaked at $35.9K in Q4 2025. 288 funds tracked by Wall St. Rank hold XENE as of Q3 2026.

  • Danske Bank held 100 shares of Xenon Pharmaceuticals worth $3.72K as of Q3 2026.
  • Danske Bank left its Xenon Pharmaceuticals share count unchanged in Q3 2026.
  • Xenon Pharmaceuticals made up ﹤0.01% of Danske Bank's portfolio in Q3 2026, its #925 holding.
  • Danske Bank first reported a position in Xenon Pharmaceuticals in Q3 2024 and has held it in 7 quarters since.
  • Danske Bank's Xenon Pharmaceuticals position peaked at $35.9K in Q4 2025.
  • 288 funds tracked by Wall St. Rank held Xenon Pharmaceuticals as of Q3 2026.

Based on Danske Bank's 13F filing for Q3 2026, filed 9 Nov 2026.